Skip to main content
|
Go home
Go home

Freenome Adds Renown Health As Partner for The Sanderson Study

Renown Health Logo

Freenome, a privately held biotech company announced today that Renown Health has joined as a partner for the Sanderson Study, Freenome’s study of its multiomics platform, in combination with real-world data to detect multiple cancers.

The study encompasses both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact.

Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to detect cancer in its earliest stages using a standard blood draw.

“We are delighted to partner with Freenome to launch this far-reaching trial which has transformative potential,” said Lee Schwartzberg, MD, medical oncology section chief and the principal investigator for the Sanderson Study at Renown. “Studying the impact of merging real-world information from patients with multiomics technology holds the promise of a truly personalized approach to early detection of cancer.”

Renown Health has multiple clinical trials currently available to patients in northern Nevada across a variety of specialties, including oncology, cardiology, neurology, pediatrics, and pulmonology.

Cancer is the second-leading cause of death in the Silver State, claiming the lives of more than 5,400 Nevadans each year. This number has increased since the last five-year plan estimates of 4,400 deaths per year.1

Promoting research to improve cancer prevention, detection, diagnosis and treatment is a key goal outlined in the Nevada Cancer Plan, 2021-2025, a framework developed by the Nevada Cancer Coalition in partnership with the Nevada Department of Health and Human Services. Access and participation in clinical trials is a key component of the plan, which, Renown says, makes participation in the Sanderson Study even more significant.

“At the inception of the William N. Pennington Cancer Institute, we committed to not only provide the very best care possible to our community, but to also help improve outcomes through participation in research,” said Max Coppes, MD, PhD, MBA, cancer center director of the William N. Pennington Cancer Institute. “The research collaboration with Freenome has the potential to make a dream come true: Finding cancer early when it’s most treatable.”

The Sanderson Study will enroll approximately 8,000 patients through Freenome’s clinical study partner network and numerous regional health systems across the United States.

“Renown is committed to making a difference in the health and well-being of patients in communities across the state of Nevada, and that includes access to innovative research,” said Lance Baldo, MD, chief medical officer at Freenome. “The combination of real-world data and multiomics is poised to transform the landscape of early cancer detection.”

Freenome’s clinical studies are named for employees’ loved ones who fought cancer. This study honors Tim Sanderson, the loving father of a Freenome engineer.

For residents of Nevada interested in participating in the Sanderson Study, contact the William N. Pennington Cancer Institute clinical research coordinators at renown-crd@renown.org.

Click here for more information on the Sanderson Study.


About Freenome

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. The company combines its deep expertise in molecular biology with advanced computational biology and machine learning to detect disease-associated patterns among billions of circulating cell-free biomarkers. Freenome is headquartered in South San Francisco, California.

About Renown Health’s William N. Pennington Cancer Institute

The William N. Pennington Cancer Research Institute provides comprehensive multidisciplinary cancer care for the northern Nevada community, helps educate the next generation of healthcare providers, and works to improve treatments and outcomes through active participation in research.

About Renown Health

Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

Related News

Renown Health board members and leaders along with Jeanne and Raymond Conrad cut the ribbon to open the Conrad Breast Center

Renown Health Opens Conrad Breast Center; First in the Region to Offer Services from Screening to Diagnosis, Surgery, Treatment, Recovery and Survivorship in One South Reno Location

ABOVE: A ribbon-cutting event on Tuesday, May 27, celebrates the Conrad Breast Center, which expands access to essential breast cancer services for all.
Read More Renown Health Opens Conrad Breast Center; First in the Region to Offer Services from Screening to Diagnosis, Surgery, Treatment, Recovery and Survivorship in One South Reno Location
Nevada Governor Joe Lombardo and Renown President and CEO Dr. Brian Erling pose for a photo as Dr. Erling accepts his Governor's Award.

Dr. Brian Erling and Renown Health Honored with Governor's Award for Pioneering First Kidney Transplant Program for Northern Nevada by Nevada Donor Network

Dr. Brian Erling, President and CEO of Renown Health, has been awarded the prestigious 2025 Governor’s Award in recognition of his visionary leadership and instrumental role in establishing the first kidney transplant program for northern Nevada. Presented at the annual Nevada Donor Network Gala by Governor Joe Lombardo at his residence in Carson City on May 8, the Governor’s Award honors individuals who have made outstanding contributions to organ, eye, and tissue donation in the state. Dr. Erling’s efforts mark a historic first for healthcare in northern Nevada, giving residents access to lifesaving transplant care close to home for the first time. “I have the distinct pleasure on behalf of the Nevada Donor Network, the great state of Nevada and myself to award the 2025 Governor’s Award to Dr. Brian Erling of Renown Health,” said Governor Joe Lombardo. Joe Ferreira, president and CEO of the Nevada Donor Network, added his congratulations. “This is a momentous step forward for our state and provides hope and healing to those awaiting transplants and their families. The expansion of essential transplantation services across our state is made possible because of an extraordinary partnership. Thank you, Dr. Erling, for paving the way for better health outcomes and a brighter future for those in need.” Dr. Erling accepted the award, saying, “Many people in this room tonight worked long and hard to bring the Renown Transplant Institute® to our region, and are so deserving of this award. I am happy, on their behalf, to accept this award. I started my healthcare career as an emergency medicine physician and sometimes had to tell families about a loved one's death. I vowed to preserve the legacy of those patients if given the chance.” He added, “When I came to Renown from Colorado, one of the first questions I asked was, with the dramatic growth in our population in northern Nevada, are we able to make additional investments in expertise and clinical programs to help keep more care local? Increasing access to health care, both preventive care and advanced treatment—is critical for a community’s well-being and optimal health.” “As a team, we thought it would be incredible if we could bring a transplant program to our area. Just think about how many people have had to travel more than four hours out of the area and rent hotel rooms for weeks. Not every person can afford that. We think about things like that because at Renown Health, we care for everyone. When people have to travel to Vegas, or Salt Lake City or California, to get the care that they need, that is a health equity issue.” “So, we stepped in, and transplant became a top priority for the entire team. We have amazing people who have made this happen. Dr. Ernesto Molmenti has 25 years of transplant experience and came from Northwell Health in New York City to help lead this program. Dr. David Mulligan, also a transplant surgeon, comes to Renown from Yale and the Mayo Clinic. Ashley Cardenas, the administrator for the Renown Transplant Institute joins us from University of California, San Diego- School of Medicine. We have recruited some amazing people.” “And here at Renown, we have so many outstanding leaders who made this happen. From Chris Nicholas, our CEO at Renown Regional Medical Center, to Dr. Rahul Mediwala, CEO of our medical group and a nephrologist who has spent years planning for this program, to Jimmy Lao, director of nursing for our Emergency Rooms, to Taralynn Basham, director of nursing for our ICUs, and everyone in between- we say, “thank you!” He finished by saying, “Thank you for the honor. We are excited to get the Renown Transplant Institute up and running, and we are looking to do our first kidney transplant within the next several weeks. Thank you, Governor, for making healthcare a priority. It has been a pleasure working with you and your administration.” Assessments Now Open for Kidney Transplant Candidates The Renown Transplant Institute® at Renown Regional Medical Center in Reno is one of only 250 transplant centers nationwide and one of only two centers in all of Nevada. The Renown team is working closely with local healthcare providers and social workers at area dialysis centers to streamline referrals and ensure a smooth transition for patients to the transplant list. The Renown Transplant Institute is now accepting referrals for kidney transplant. Candidates will undergo a thorough evaluation process to determine their eligibility and readiness for a transplant. Physicians may now refer patients, or people with end-stage kidney disease who wish to be screened for a kidney transplant by Dr. Narisorn Atsava-Svate and Dr. Ernesto Molmenti, to call 1-833-RING-NTI (746-4684). For more information visit https://www.renown.org/locations/renown-transplant-institute and https://www.nvtransplant.org/. It is anticipated that the first kidney transplant surgeries will take place by July. To join the fight, donate to the Renown Health Foundation, a non-profit organization registered with the State of Nevada and recognized by the IRS as a 501(c)(3) entity at www.renown.org/donate or 775-982-5545. As the region’s only Level 2 Trauma Center for adults and children, Renown serves over 1 million people and 100,000 square miles. In U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 Hospital for the State of Nevada for 2024, 2023 and 2022.
Read More Dr. Brian Erling and Renown Health Honored with Governor's Award for Pioneering First Kidney Transplant Program for Northern Nevada by Nevada Donor Network
View All Press Releases
ER Wait Times

How are wait times calculated?

Our estimated ER wait times reflect the average time from check-in to being seen by a medical professional during triage, where patients are prioritized based on the severity of their condition.